AstraZeneca
An Executive Director, Strategy, Oncology R&D at AstraZeneca leads the development and delivery of therapeutic area strategies for oncology to inform portfolio and investment priorities. The role integrates clinical, scientific, and commercial insights and partners with senior executives and cross-functional teams to maximize return on investment and improve patient outcomes.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Director, Oncology R&D Strategy and Portfolio Management
BioLife Plasma Services
Oncology Strategy Director
lifelancer
Executive Director Global Project Leader, Oncology R&D
American Association of Physicists in Medicine
Senior Director, Competitive Intelligence, Oncology R&D
lifelancer
Executive Director, Oncology Business Unit, Strategy
lifelancer
Oncology Strategy Director
Amgen